204 related articles for article (PubMed ID: 19114095)
41. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
Cole PD; Zebala JA; Alcaraz MJ; Smith AK; Tan J; Kamen BA
Cancer Chemother Pharmacol; 2006 Jun; 57(6):826-34. PubMed ID: 16170572
[TBL] [Abstract][Full Text] [Related]
42. [Usefulness of local administration of methotrexate bound to activated carbon particles (MTX-CH)].
Ito T; Takagi T; Shimomura K; Takemura M; Toma A; Fujiyama J; Sonoyama Y; Sakakura C; Ootsuji E; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1696-8. PubMed ID: 11708012
[TBL] [Abstract][Full Text] [Related]
43. Thermosensitive gemcitabine-magnetoliposomes for combined hyperthermia and chemotherapy.
Ferreira RV; Martins TM; Goes AM; Fabris JD; Cavalcante LC; Outon LE; Domingues RZ
Nanotechnology; 2016 Feb; 27(8):085105. PubMed ID: 26820520
[TBL] [Abstract][Full Text] [Related]
44. A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.
Abolmaali SS; Tamaddon AM; Dinarvand R
Cancer Chemother Pharmacol; 2013 May; 71(5):1115-30. PubMed ID: 23292116
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.
Doddoli C; Ghez O; Barlési F; D'journo B; Robitail S; Thomas P; Clerc T
Int J Pharm; 2005 Jun; 297(1-2):180-9. PubMed ID: 15869851
[TBL] [Abstract][Full Text] [Related]
46. Liposome-encapsulated methotrexate interactions with human chronic lymphocytic leukemia cells.
Todd JA; Levine AM; Tökés ZA
J Natl Cancer Inst; 1980 Apr; 64(4):715-9. PubMed ID: 6928985
[TBL] [Abstract][Full Text] [Related]
47. Hydroxy fatty acid based polyanhydride as drug delivery system: synthesis, characterization, in vitro degradation, drug release, and biocompatibility.
Jain JP; Modi S; Kumar N
J Biomed Mater Res A; 2008 Mar; 84(3):740-52. PubMed ID: 17635032
[TBL] [Abstract][Full Text] [Related]
48. Ofloxacin targeting to lungs by way of microspheres.
Harsha S; R C; Rani S
Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
[TBL] [Abstract][Full Text] [Related]
49. Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice.
Chandraprakash KS; Udupa N; Umadevi P; Pillai GK
J Drug Target; 1993; 1(2):143-5. PubMed ID: 8069552
[TBL] [Abstract][Full Text] [Related]
50. Controllable release from high-transition temperature magnetoliposomes by low-level magnetic stimulation.
Spera R; Apollonio F; Liberti M; Paffi A; Merla C; Pinto R; Petralito S
Colloids Surf B Biointerfaces; 2015 Jul; 131():136-40. PubMed ID: 26042528
[TBL] [Abstract][Full Text] [Related]
51. [Preparation of amylopectin modified dipyridamole liposome and its tissue distribution in mice].
Cheng J; Zhu JB; Yang SX; Wang CB
Yao Xue Xue Bao; 2006 Mar; 41(3):277-81. PubMed ID: 16759003
[TBL] [Abstract][Full Text] [Related]
52. Neuropharmacokinetic evaluation of methotrexate-loaded chitosan nanogels.
Azadi A; Rouini MR; Hamidi M
Int J Biol Macromol; 2015 Aug; 79():326-35. PubMed ID: 25959975
[TBL] [Abstract][Full Text] [Related]
53. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
54. [Study on preparation and thermosensitive release property of composite phospholipid liposomes containing total alkaloids from Strychnos nux-vomica].
He CQ; Hu MY; Zhang H; Chang H; Chen J; Cai BC
Zhongguo Zhong Yao Za Zhi; 2013 May; 38(9):1366-70. PubMed ID: 23944070
[TBL] [Abstract][Full Text] [Related]
55. Influence of molecular architecture of polyether-co-polyester dendrimers on the encapsulation and release of methotrexate.
Dhanikula RS; Hildgen P
Biomaterials; 2007 Jul; 28(20):3140-52. PubMed ID: 17428531
[TBL] [Abstract][Full Text] [Related]
56. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
57. Preparation and characterization of extruded magnetoliposomes.
Sabaté R; Barnadas-Rodríguez R; Callejas-Fernández J; Hidalgo-Alvarez R; Estelrich J
Int J Pharm; 2008 Jan; 347(1-2):156-62. PubMed ID: 17692483
[TBL] [Abstract][Full Text] [Related]
58. Gelatin-methotrexate conjugate microspheres as a potential drug delivery system.
Pica K; Tchao R; Ofner CM
J Pharm Sci; 2006 Sep; 95(9):1896-908. PubMed ID: 16850436
[TBL] [Abstract][Full Text] [Related]
59. [Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH)].
Fujiyama J; Nakase Y; Mochizuki S; Togawa T; Suzuki G; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1844-6. PubMed ID: 15553734
[TBL] [Abstract][Full Text] [Related]
60. Rational synthesis of magnetic thermosensitive microcontainers as targeting drug carriers.
Chen LB; Zhang F; Wang CC
Small; 2009 Mar; 5(5):621-8. PubMed ID: 19189322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
